Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Norwegian Prednisolone in Early Psychosis Study - NorPEPS. The Role of Immune-modulating Strategies in the Treatment of Psychosis

NCT03340909 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT03340909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03340909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Norwegian Prednisolone in Early Psychosis Study - NorPEPS. The Role of Immune-modulating Strategies in the Treatment of Psychosis
Lead sponsor
Haukeland University Hospital
Phase
Phase 2
Overall status
Terminated
Start date
February 2, 2018
Completion date
December 31, 2021
Enrollment
12 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive change, immune suppression, psychosis, schizophrenia and related disorders